−0.15EUR
−6.16 MEUR
23.13 MEUR
10.85 M
About PHILOGEN
Sector
CEO
Dario Neri
Headquarters
Siena
Website
Employees (FY)
165
Founded
1996
ISIN
IT0005373789
FIGI
BBG000QL1KW3
Philogen SpA engages engineering and clinical development of lead products capable of targeting angiogenesis. Its products include Nidlegy, Fibromun, Darleukin, Dodekin, and Dekavil. The company was founded by Dario Neri, Duccio Neri, and Giovanni Neri in 1996 and is headquartered in Siena, Italy.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PHIL is 18.05 EUR — it has decreased by 1.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange PHILOGEN stocks are traded under the ticker PHIL.
PHILOGEN is going to release the next earnings report on Sep 25, 2024. Keep track of upcoming events with our Earnings Calendar.
PHIL stock is 1.39% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is PHILOGEN there?
One year price forecast for PHILOGEN has a max estimate of 25.00 EUR and a min estimate of 22.00 EUR.
PHIL earnings for the last quarter are 0.19 EUR whereas the estimation was −0.23 EUR which accounts for 182.61% surprise. Estimated earnings for the next quarter are −0.29 EUR. See more details about PHILOGEN earnings.
PHILOGEN revenue for the last quarter amounts to 22.52 M EUR despite the estimated figure of 7.00 M EUR. In the next quarter revenue is expected to reach 4.10 M EUR.
Yes, you can track PHILOGEN financials in yearly and quarterly reports right on TradingView.
PHIL stock has fallen by 0.28% compared to the previous week, the month change is a 3.14% rise, over the last year PHILOGEN has showed a 15.71% increase.
PHIL net income for the last quarter is −13.83 M EUR, while the quarter before that showed 7.67 M EUR of net income which accounts for −280.31% change. Track more PHILOGEN financial stats to get the full picture.
Today PHILOGEN has the market capitalization of 529.26 M, it has increased by 1.42% over the last week.
No, PHIL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PHIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHILOGEN stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 165.00 employees. See our rating of the largest employees — is PHILOGEN on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHILOGEN technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHILOGEN stock shows the buy signal. See more of PHILOGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PHILOGEN future price: according to them, PHIL price has a max estimate of 25.00 EUR and a min estimate of 22.00 EUR. Read a more detailed PHILOGEN forecast: see what analysts think of PHILOGEN and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHILOGEN EBITDA is −7.19 M EUR, and current EBITDA margin is −31.09%. See more stats in PHILOGEN financial statements.